Shares of the Danish drugmaker have soared 40% so far this year, boosted by an explosion in demand for its weight-loss drugs Wegovy and Ozempic. At the close of trading Monday, Novo Nordisk had a market capitalization of 2.96 trillion Danish krone .
’s market value was around $416 billion. The French firm — which sells Louis Vuitton handbags and Hennessy cognac — has been hurt by the slowing Chinese economy. Its stock has dropped 8% over the past six months, trimming this year’s gains to 12%. Sales of Wegovy and Ozempic have skyrocketed in recent months. Ozempic is a drug developed to treat type 2 diabetes that contains the same active ingredient as Wegovy, and which some physicians have prescribed to patients to help them lose weight.
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر: